Patients suffering from four different kinds of cancer might soon benefit from advances in biotechnology in Taiwan.
According to Jacqueline Whang-Peng (彭汪嘉康), director of the National Health Research Institute's cancer division (國家衛生研究院), the research center has entered Phase I clinical trials for gene therapies useful on advanced colon cancer and advanced lung cancer.
Gene therapy is the transfer of genetic material into the cells of an organism in order to treat disease, a form of treatment started with failures in the 1970s that has begun to see success only in the past decade.
Although professionals within the biotech field were not surprised by news of the gene therapies entering Phase I clinical trials, the advance is significant for the nation's research success.
The national research organization has also been working on dendritic cell immunotherapy for advanced nasopharyngel carcinoma -- a type of nose cancer -- and on liver cancer, two of the most common cancers in Asia.
In this form of therapy, dendritic cells from the cancer patient are used as a vehicle to deliver treatments against cancer cells. While dendritic cells have been proven to be excellent vehicles, there has been little success working out exactly how to use them for treatment delivery. The nose cancer immunotherapy was administered to 12 patients and showed no side effects, while 4.5 patients showed partial remission of the cancer, according to Peng.
DOLLAR CHALLENGE: BRICS countries’ growing share of global GDP threatens the US dollar’s dominance, which some member states seek to displace for world trade US president-elect Donald Trump on Saturday threatened 100 percent tariffs against a bloc of nine nations if they act to undermine the US dollar. His threat was directed at countries in the so-called BRICS alliance, which consists of Brazil, Russia, India, China, South Africa, Egypt, Ethiopia, Iran and the United Arab Emirates. Turkey, Azerbaijan and Malaysia have applied to become members and several other countries have expressed interest in joining. While the US dollar is by far the most-used currency in global business and has survived past challenges to its preeminence, members of the alliance and other developing nations say they are fed
LIMITED MEASURES: The proposed restrictions on Chinese chip exports are weaker than previously considered, following lobbying by major US firms, sources said US President Joe Biden’s administration is weighing additional curbs on sales of semiconductor equipment and artificial intelligence (AI) memory chips to China that would escalate the US crackdown on Beijing’s tech ambitions, but stop short of some stricter measures previously considered, said sources familiar with the matter. The restrictions could be unveiled as soon as next week, said the sources, who emphasized that the timing and contours of the rules have changed several times, and that nothing is final until they are published. The measures follow months of deliberations by US officials, negotiations with allies in Japan and the Netherlands, and
Foxconn Technology Group (富士康科技集團) yesterday said it expects any impact of new tariffs from US president-elect Donald Trump to hit the company less than its rivals, citing its global manufacturing footprint. Young Liu (劉揚偉), chairman of the contract manufacturer and key Apple Inc supplier, told reporters after a forum in Taipei that it saw the primary impact of any fresh tariffs falling on its clients because its business model is based on contract manufacturing. “Clients may decide to shift production locations, but looking at Foxconn’s global footprint, we are ahead. As a result, the impact on us is likely smaller compared to
TECH COMPETITION: The US restricted sales of two dozen types of manufacturing equipment and three software tools, and blacklisted 140 more Chinese entities US President Joe Biden’s administration unveiled new restrictions on China’s access to vital components for chips and artificial intelligence (AI), escalating a campaign to contain Beijing’s technological ambitions. The US Department of Commerce slapped additional curbs on the sale of high-bandwidth memory (HBM) and chipmaking gear, including that produced by US firms at foreign facilities. It also blacklisted 140 more Chinese entities that it accused of acting on Beijing’s behalf, although it did not name them in an initial statement. Full details on the new sanctions and Entity List additions were to be published later yesterday, a US official said. The US “will
RSS